TKXHF yields 173913.04% · PFE yields 6.13%● Live data
📍 TKXHF pulled ahead of the other in Year 1
Combined, TKXHF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TKXHF + PFE for your $10,000?
TrackX Holdings Inc., an enterprise asset management company, deploys Software-as-a-Solutions for use in the tracking and management of physical assets primarily in the United States. Its solutions include TrackX GAME (Global Asset Management for Enterprises), an industrial Internet of Things (IoT) platform that provides item level tracking, workflow processing, event management, alerting, and analytics to deliver solutions across various industries. The company's GAME solution is used in the recreational vehicle and IT asset tracking; supply chain velocity; IoT device; data capture and predictive analytic; and returnable transportation item and reusable asset management. It serves customers in industries, such as beverage, brewery, transportation, automotive, hi-tech, hospitality, mining, agriculture, horticulture, and manufacturing, as well as government. TrackX Holdings Inc. is headquartered in Denver, Colorado.
Full TKXHF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.